Peripheral Artery Disease (PAD)
There remains a significant unrealized demand for a novel technology solution to safely and effectively address highly fibro-calcific lesions and arrive at the interventional goal: restore flow, promote wound healing and prevent amputations.
1. The SAGE Group
2. Abu Dabrh AM, et al. J Vasc Surg. 2015;62(6):1642–1651. [PubMed] [Google Scholar]
3. Norgren L, et al. J Vasc Surg. 2007;45(suppl S):S5–S67. [PubMed] [Google Scholar]
4. Murabito JM et al. Am Heart J. 2002;143(6):961–965. [PubMed] [Google Scholar]
5. Fanelli, J Cardiovasc Surg 2014
6. van der Heijden FH, et al. Br J Surg. 1993
Coronary Artery Disease (CAD)
The most common treatment for patients is percutaneous coronary intervention (PCI), which involves devices to facilitate angioplasty and stenting. There are one (1) million PCI procedures performed each year in the US alone.
It is estimated that 30-40% of patients undergoing PCI have calcification as determined by coronary angiography1,2. Moreover, the prevalence of chronic total occlusions in patients with coronary artery disease is as high as 52%3,4.
There is demand for safer, simpler, and more effective solutions that can increase the success rate of PCI procedures in complex calcific cases, and ultimately narrow the gap between the expert operators and the other interventional cardiologists.
1. Jeroudi OM, et al. Catheter Cardiovasc Interv. 2014
2. Mintz GS, et al. Circulation. 1995
3. Tsai TT, et al. JACC Cardiovasc Interv. 2017
4. Young MN, et al Circ Cardiovasc Interv. 2019;
5. Sakes, A. et al, Cardiovascular Engineering and Technology, 2016